Bio-Rad Laboratories, Inc


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549


Form 8-K


CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report:  November 2, 2006

(Date of earliest event reported)


 

BIO-RAD LABORATORIES, INC.

(Exact name of registrant as specified in its charter)


Commission file number 1-7928


Delaware

 

94-1381833

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

1000 Alfred Nobel Drive, Hercules, California

 

94547

(Address of principal executive offices)

 

(Zip Code)

 

(510) 724-7000

Registrant's telephone number, including area code

 

 

ITEM 2.02.

RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

 

The information in Item 2.02 of the Report, including Exhibit 99.1 attached hereto, is being furnished

pursuant to Item 2.02 of Form 8-K.  Consequently, it is not deemed “filed” for the purposes of Section 18

of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that

section.  It may only be incorporated by reference in another filing under the Exchange Act or

Securities Act of 1933, as amended, if such subsequent filing specifically references this Form 8-K.

 

On November 2, 2006, Bio-Rad Laboratories, Inc. announced its results of operations and financial

condition as of and for the quarter ended September 30, 2006.  A copy of the press release is attached

hereto as Exhibit 99.1 and is incorporated herein by reference.

 






Item 9.01

FINANCIAL STATEMENTS AND EXHIBITS

 

 

 

 

(c)

Exhibits

 

 


Exhibit

 

 

Number

 

Description

99.1

 

Press Release for third quarter 2006 financial results of

 

 

Bio-Rad Laboratories, Inc., dated November 2, 2006.  This exhibit is

 

 

being furnished pursuant to Item 2.02 of Form 8-K.





SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly

caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

BIO-RAD LABORATORIES, INC.

 

 

 

 

Date:  November 2, 2006

/s/ Christine A. Tsingos

 

Christine A. Tsingos

 

Vice President and

 

  Chief Financial Officer






EXHIBIT INDEX

 

 

 

 

 

 

Exhibit

 

 

Number

 

Description

99.1

 

Press Release for third quarter 2006 financial results of

 

 

Bio-Rad Laboratories, Inc., dated November 2, 2006.  This exhibit is

 

 

being furnished pursuant to Item 2.02 of Form 8-K.